J0578
HCPCSInj brixadi, more than 7 day
Official HCPCS Level II long descriptor
Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapy
HCPCS Level II code J0578 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj brixadi, more than 7 day
Added to HCPCS: 2024-04-01
Nearby codes in J0
- J0567Inj., cerliponase alfa 1 mg
- J0570Buprenorphine implant 74.2mg
- J0571Buprenorphine oral 1mg
- J0572Bupren/nal up to 3mg bupreno
- J0573Bupren/nal 3.1 to 6mg bupren
- J0574Bupren/nal 6.1 to 10mg bupre
- J0575Bupren/nal over 10mg bupreno
- J0577Inj, brixadi, 7 days or less
- J0582Bivalirudin (endo) 1 mg
- J0583Bivalirudin
- J0584Injection, burosumab-twza 1m
- J0585Injection,onabotulinumtoxina
- J0586Abobotulinumtoxina
- J0587Inj, rimabotulinumtoxinb
- J0588Incobotulinumtoxin a
- J0589Inj daxibotulinumtoxina-lanm
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.